Owners, management and financials
CVR: 19670694
Secondary names: RECEPTOR TECHNOLOGIES A/S
Not available
Net result: DKK -471,043
Acadia Pharmaceuticals Inc. (100%)
CVR · view owners
Jennifer Jane Rhodes
Board: Martin Choy (chair) and 3 members
CVR · view management
Active
Founded 1 November 1996
CVR · view overview
6 employees
CVR · 2005
Director role ended: Austin Kim
CVR · 02/05/2024
View the full event history
ACADIA PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1996. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Jennifer Jane Rhodes. The board consists of Martin Choy (chair), James Kenji Kihara, Jennifer Jane Rhodes and Peter Francis Chae. The company is owned by Acadia Pharmaceuticals Inc.. The company has 6 employees (2005). In 2025, the company reported a net result of DKK -471,043 compared with DKK -99,365 the year before. Equity in the 2025 report amounted to DKK -1,563,180.
Selskabets formål er at drive fabrikation af, handel med og forskning i medicinske, farmaceutiske, kemiske og tekniske produkter, processer og anlæg, samt anden i forbindelse hermed stående virksomhed efter bestyrelsens nærmere bestemmelse.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | -471 t. | 14 t. | -1.6 mio. | 0 | |
| 202401/01/2024 – 31/12/2024 | - | -99 t. | 55 t. | -1.1 mio. | 0 | |
| 202301/01/2023 – 31/12/2023 | -151 t. | -151 t. | 3 t. | -993 t. | 0 | |
| 202201/01/2022 – 31/12/2022 | -254 t. | -254 t. | 5 t. | -841 t. | 0 | |
| 202101/01/2021 – 31/12/2021 | -21 t. | -21 t. | 6 t. | -588 t. | 0 | |
| 202001/01/2020 – 31/12/2020 | - | -57 t. | 11 t. | -567 t. | 0 | |
| 201901/01/2019 – 31/12/2019 | - | -75 t. | 3 t. | -510 t. | 0 | |
| 201801/01/2018 – 31/12/2018 | - | -47 t. | 6 t. | -435 t. | 0 | |
| 201701/01/2017 – 31/12/2017 | - | -74 t. | 7 t. | -388 t. | 0 | |
| 201601/01/2016 – 31/12/2016 | - | -45 t. | 4 t. | -315 t. | - | |
| 201501/01/2015 – 31/12/2015 | - | -56 t. | 5 t. | -270 t. | - | |
| 201401/01/2014 – 31/12/2014 | - | -147 t. | 9 t. | -214 t. | - | |
| 201301/01/2013 – 31/12/2013 | - | -57 t. | 5 t. | -67 t. | - | |
| 201201/01/2012 – 31/12/2012 | - | -258 t. | 4 t. | -10 t. | - |
Compared to 1.040 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of ACADIA PHARMACEUTICALS A/S is 19670694.
ACADIA PHARMACEUTICALS A/S is owned by Acadia Pharmaceuticals Inc..
The management of ACADIA PHARMACEUTICALS A/S consists of Jennifer Jane Rhodes.
The board of ACADIA PHARMACEUTICALS A/S consists of Martin Choy, James Kenji Kihara and Jennifer Jane Rhodes, with Martin Choy as chair.
ACADIA PHARMACEUTICALS A/S had 6 employees in 2005 according to the Danish CVR register.
ACADIA PHARMACEUTICALS A/S was founded on 1 November 1996.
Claim this page to add your logo and social links. Free to get started.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2025. The net result was DKK -471,043.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2024. The net result was DKK -99,365.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2023. Gross profit came to DKK -151,395, and the net result was DKK -151,395.
As of May 2, 2024, Jennifer Jane Rhodes has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 2, 2024, Peter Francis Chae has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 2, 2024, Austin Kim has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 2, 2024, Jennifer Jane Rhodes is registered as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of May 2, 2024, Austin Kim has stepped down as adm. dir. of ACADIA PHARMACEUTICALS A/S.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2022. Gross profit came to DKK -253,519, and the net result was DKK -253,577.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2021. Gross profit came to DKK -21,167, and the net result was DKK -21,200.
As of July 6, 2022, James Kenji Kihara has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of July 6, 2022, Elena Heather Ridloff has left the board of directors of ACADIA PHARMACEUTICALS A/S.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2020. The net result was DKK -56,866.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2019. The net result was DKK -74,706.
As of November 18, 2019, Martin Choy has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of November 18, 2019, Elena Heather Ridloff has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of November 18, 2019, Eric Miller has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of November 17, 2019, Martin Choy has left the board of directors of ACADIA PHARMACEUTICALS A/S.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2018. The net result was DKK -46,546.
As of May 27, 2019, Eric Miller has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 27, 2019, Austin Kim has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 27, 2019, Justin Thacker has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 27, 2019, Todd Young has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 27, 2019, Austin Kim is registered as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of May 27, 2019, Todd Young has stepped down as adm. dir. of ACADIA PHARMACEUTICALS A/S.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2017. The net result was DKK -73,652.
As of May 31, 2018, Justin Thacker has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 31, 2018, Todd Young has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 31, 2018, Martin Choy has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 31, 2018, Glenn Frederick Baity has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 31, 2018, Todd Young is registered as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of May 31, 2018, Glenn Frederick Baity has stepped down as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of May 30, 2018, Justin Thacker has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 30, 2018, Todd Young has left the board of directors of ACADIA PHARMACEUTICALS A/S.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2016. The net result was DKK -44,570.
As of May 23, 2017, Justin Thacker has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 23, 2017, Todd Young has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 23, 2017, Torsten Erik Rasmussen has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 23, 2017, Uli Alf Hacksell has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 23, 2017, Glenn Frederick Baity is registered as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of May 23, 2017, Uli Alf Hacksell has stepped down as adm. dir. of ACADIA PHARMACEUTICALS A/S.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2015. The net result was DKK -56,389.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2014. The net result was DKK -146,995.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2013. The net result was DKK -57,074.
As of May 26, 2014, Glenn Frederick Baity has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 26, 2014, Thomas Aasen has left the board of directors of ACADIA PHARMACEUTICALS A/S.
ACADIA PHARMACEUTICALS A/S has published its annual report for 2012. The net result was DKK -258,034.
As of March 31, 2010, Torsten Erik Rasmussen has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of March 31, 2010, Thomas Aasen has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of March 31, 2010, Uli Alf Hacksell has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of March 31, 2010, Bo-Ragnar Tolf has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of March 31, 2010, Uli Alf Hacksell is registered as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of March 31, 2010, Bo-Ragnar Tolf has stepped down as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of May 27, 2009, A/S PSE NR. 4820 has stepped down as auditor of ACADIA PHARMACEUTICALS A/S.
As of February 8, 2007, Bo-Ragnar Tolf has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of February 8, 2007, Mark Robert Brann has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of May 29, 2006, Martinus Adrianus van Osch has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of June 30, 2005, A/S PSE NR. 4820 has been appointed auditor of ACADIA PHARMACEUTICALS A/S.
As of June 30, 2005, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of ACADIA PHARMACEUTICALS A/S.
As of October 8, 2003, Martinus Adrianus van Osch has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of October 8, 2003, Arne Gillin has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of October 8, 2003, Povl Krogsgaard-Larsen has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of January 1, 2001, Bo-Ragnar Tolf is registered as adm. dir. of ACADIA PHARMACEUTICALS A/S.
As of January 1, 2001, Uli Alf Hacksell has stepped down as director of ACADIA PHARMACEUTICALS A/S.
As of June 22, 2000, A/S PSE NR. 4820 has been appointed auditor of ACADIA PHARMACEUTICALS A/S.
As of June 22, 2000, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of ACADIA PHARMACEUTICALS A/S.
As of June 22, 2000, A/S PSE NR. 4820 has stepped down as auditor of ACADIA PHARMACEUTICALS A/S.
As of June 22, 2000, A/S PSE NR. 4820 has stepped down as auditor of ACADIA PHARMACEUTICALS A/S.
As of May 25, 1999, Uli Alf Hacksell is registered as director of ACADIA PHARMACEUTICALS A/S.
As of May 25, 1999, Anni Lotte Kirstine Pedersen has stepped down as director of ACADIA PHARMACEUTICALS A/S.
As of March 20, 1998, Povl Krogsgaard-Larsen has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of March 20, 1998, Peter Høngård Andersen has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of March 20, 1998, Anni Lotte Kirstine Pedersen is registered as director of ACADIA PHARMACEUTICALS A/S.
As of March 20, 1998, Peter Høngård Andersen has stepped down as director of ACADIA PHARMACEUTICALS A/S.
As of March 25, 1997, is registered as an owner of ACADIA PHARMACEUTICALS A/S with an ownership share of 100%.
As of February 4, 1997, A/S PSE NR. 4820 has been appointed auditor of ACADIA PHARMACEUTICALS A/S.
As of February 4, 1997, Nis Jørn Bennetzen has stepped down as auditor of ACADIA PHARMACEUTICALS A/S.
As of February 4, 1997, Peter Høngård Andersen has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of February 4, 1997, Arne Gillin has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of February 4, 1997, Mark Robert Brann has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of February 4, 1997, Victor Christoffersen has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of February 4, 1997, Sebastian Benjamin Bahn Christoffersen has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of February 4, 1997, Helen Mimi Janniche has left the board of directors of ACADIA PHARMACEUTICALS A/S.
As of February 4, 1997, Peter Høngård Andersen is registered as director of ACADIA PHARMACEUTICALS A/S.
As of February 4, 1997, Victor Christoffersen has stepped down as director of ACADIA PHARMACEUTICALS A/S.
As of November 1, 1996, Nis Jørn Bennetzen has been appointed auditor of ACADIA PHARMACEUTICALS A/S.
As of November 1, 1996, Victor Christoffersen has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of November 1, 1996, Sebastian Benjamin Bahn Christoffersen has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of November 1, 1996, Helen Mimi Janniche has joined the board of directors of ACADIA PHARMACEUTICALS A/S.
As of November 1, 1996, Victor Christoffersen is registered as director of ACADIA PHARMACEUTICALS A/S.
ACADIA PHARMACEUTICALS A/S was founded on November 1, 1996.
Companies in the same industry and area
CVR 46282744
CVR 44805472
CVR 41093447
CVR 45943062
CVR 36920246
